Skip to main content
main-content

Zeitschrift

Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy 11-12/2002

Ausgabe 11-12/2002

Inhaltsverzeichnis ( 12 Artikel )

01.12.2002 | Review | Ausgabe 11-12/2002

Adjuvant immunotherapy for solid tumors: from promise to clinical application

Simone Mocellin, Carlo R. Rossi, Mario Lise, Francesco M. Marincola

01.12.2002 | Original Article | Ausgabe 11-12/2002

Linomide administration following bone marrow transplantation in mice

Lola Weiss, Ali Abdul-Hai, Yoel Shufaro, Shoshanna Reich, Shimon Slavin

01.12.2002 | Original Article | Ausgabe 11-12/2002

The combination of a chemokine, cytokine and TCR-based T cell stimulus for effective gene therapy of cancer

Stephane Paul, Etienne Regulier, Yves Poitevin, Horst Hormann, Bruce R. Acres

01.12.2002 | Original Article | Ausgabe 11-12/2002

Mucin gene (MUC1) transfected dendritic cells as vaccine: results of a phase I/II clinical trial

Gabriele Pecher, Arnt Häring, Lothar Kaiser, Eckhard Thiel

01.12.2002 | Original Article | Ausgabe 11-12/2002

Analysis of the antibody repertoire of lymphoma patients

Shaoming Huang, Klaus-Dieter Preuss, Xiaoxun Xie, Evi Regitz, Michael Pfreundschuh

01.12.2002 | Original Article | Ausgabe 11-12/2002

Phase I/II study of sequential chemoimmunotherapy (SCIT) for metastatic melanoma: outpatient treatment with dacarbazine, granulocyte-macrophage colony-stimulating factor, low-dose interleukin-2, and interferon-alpha

Gerard Groenewegen, Andries Bloem, Gijsbert C. de Gast

01.12.2002 | Original Article | Ausgabe 11-12/2002

Calcitonin-specific antitumor immunity in medullary thyroid carcinoma following dendritic cell vaccination

Matthias Schott, Joachim Feldkamp, Melanie Klucken, Guido Kobbe, Werner A. Scherbaum, Jochen Seissler

01.12.2002 | Original Article | Ausgabe 11-12/2002

Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial

Angela Märten, Dimitri Flieger, Sabine Renoth, Silvia Weineck, Peter Albers, Markus Compes, Björn Schöttker, Carsten Ziske, Steffen Engelhart, Peter Hanfland, Ludmila Krizek, Cora Faber, Alexander von Ruecker, Stefan Müller, Tilman Sauerbruch, Ingo G. Schmidt-Wolf

01.12.2002 | Original Article | Ausgabe 11-12/2002

41.8°C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases

Djordje Atanackovic, Axel Nierhaus, Michael Neumeier, Dieter K. Hossfeld, Susanna Hegewisch-Becker

01.12.2002 | Original Article | Ausgabe 11-12/2002

Efficient carcinoma cell killing by activated polymorphonuclear neutrophils targeted with an Ep-CAM×CD64 (HEA125×197) bispecific antibody

Christof Schweizer, Gudrun Strauss, Matthias Lindner, Alexander Marmé, Yashwant M. Deo, Gerhard Moldenhauer

01.12.2002 | Original Article | Ausgabe 11-12/2002

Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A*2402-binding residues

Akihiro Tsuboi, Yoshihiro Oka, Keiko Udaka, Masaki Murakami, Tomoki Masuda, Akiko Nakano, Hiroko Nakajima, Masaki Yasukawa, Akio Hiraki, Yusuke Oji, Manabu Kawakami, Naoki Hosen, Tatsuya Fujioka, Fei Wu, Yuki Taniguchi, Sumiyuki Nishida, Momotaro Asada, Hiroyasu Ogawa, Ichiro Kawase, Haruo Sugiyama

01.12.2002 | Symposium Series | Ausgabe 11-12/2002

Synopsis of the 4th Walker's Cay Meeting on Cancer Vaccines, 7–10 March 2002

Malcolm S. Mitchell, Martin W. Kast

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise